Our laboratory has demonstrated that bone morphogenetic protein 13 prevented the effects of annular injury in an ovine model, maintaining intervertebral disc height, cell numbers and increasing extracellular matrix production compared to degenerated controls. The present study sought to examine the molecular effects of bone morphogenetic protein 13 on human degenerated disc cells and localize its expression in both human degenerate and scoliotic disc tissue. Effect of bone morphogenetic protein 13 on human derived nucleus pulposus, annulus fibrosus and endplate cells cultured in alginate beads was evaluated by changes in proteoglycan and collagen content. Migratory potential of disc cells towards bone morphogenetic protein 13 was also examined. Bone morphogenetic protein 13 induced significant proteoglycan accumulation in nucleus (18%), annulus (21%) and endplate (23%) cells cultured in alginate beads (p < 0.05) compared to controls. Further bone morphogenetic protein 13 increased collagen I and II protein expression in nucleus and endplate cells. Nucleus cells displayed a significant chemotactic response towards bone morphogenetic protein 13. The endogenous expression of bone morphogenetic protein 13 in degenerate disc tissue was not different to scoliotic disc. Bone morphogenetic protein 13 has the potential to enhance extracellular matrix accumulation and induce cell migration in certain disc cells. Keywords: bone morphogenetic protein 13; human intervertebral disc; low back pain; cell migration; intervertebral disc degeneration Chronic low back pain is strongly associated with intervertebral disc (IVD) degeneration. IVD consists of a central gelatinous nucleus pulposus (NP), surrounded circumferentially by annulus fibrosus (AF) and separated from the vertebral bodies by cartilaginous endplates (EPs). During IVD degeneration, cellular viability is decreased and the gel-like composition of NP becomes fibrous. Additionally, there is increasing irregularity and bifurcation of the lamellar structure of AF.
1Biological therapies aim to retard IVD degeneration and re-establish its biological function by restoring cellular viability and extracellular matrix (ECM). Growth factors such as bone morphogenetic proteins (BMPs), members of transforming growth factor beta (TGF-b) superfamily, play a critical role in stimulation of ECM formation and maintenance of cell numbers. The effect of BMPs on degenerate IVDs in vitro and in vivo has been extensively studied, 2 however, the role of BMP-13 in disc regeneration has not been explored. BMP-13, the human homologue of murine growth and differentiation factor 6, 3 has been highly associated with the stimulation of ECM production. BMP-13 induced aggrecan gene expression and proteoglycan (PG) synthesis in mouse mesenchymal cell line 4 and human articular chondrocytes.5 BMP-13 also stimulated gene expression of collagen II in mouse mesenchymal cell line 4 and collagen synthesis in juvenile bovine articular cartilage explants. 6 Moreover, Zhang et al.have demonstrated t...